Overview
- The State of Texas filed suit on Nov. 20 naming Bristol-Myers Squibb and Sanofi-Aventis U.S. in the 71st District Court of Harrison County.
- The complaint alleges the companies failed to disclose that Plavix can be ineffective for many patients, particularly Black, East Asian, and Pacific Islander individuals, due to genetic metabolism differences.
- Texas cites the Deceptive Trade Practices Act and the Healthcare Program Fraud Prevention Act and claims billions in wasted taxpayer funds, including Texas Medicaid spending.
- Attorney General Ken Paxton brought the case with private counsel from McKool Smith and The Lanier Law Firm, and public statements accuse the companies of putting profits over patient safety.
- The filing is at an initial stage with no case number reported and no company responses noted in the coverage.